AVANIR PHARMACEUTICALS, INC.: key financial figures for fiscal year 2014 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2014)
- $115.0M
- Net Income/Loss (FY2014)
- -$50.4M
- Total Assets (FY2014)
- $307.0M
- Total Equity (FY2014)
- $273.4M
- Cash Flows from Operating Activities (FY2014)
- -$48.7M
Source: AVANIR PHARMACEUTICALS, INC. 10-K filing (FY2014). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
